Inapill

Biotechnology Research • Berkeley, California, United States • 1-10 Employees

Company overview

Headquarters	2625 Durant Ave, Berkeley, California 94704, US
Website	inapill.com
NAICS	541714
Founded	2023
Employees	1-10

Key Contact at Inapill

Greg Timblin

CEO & co-founder

Inapill Email Formats

Inapill uses 1 email format. The most common is {first name} (e.g., john@inapill.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@inapill.com	100%

About Inapill

Inapill is developing 1st-in-class small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of inflammatory, autoimmune, and age-related diseases. Inapill was co-founded by Greg Timblin, Josh Farahzad, and the therapeutics team @ General Inception, and is a tenant at the Bakar BioEnginuity Hub & Bakar Bio Labs @ UC Berkeley.

Inapill revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Inapill has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Inapill has never raised funding before.

Frequently asked questions

Inapill is located in Berkeley, California, US.

Inapill was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Inapill has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Inapill

Greg Timblin

CEO & co-founder

4.8

40,000 users